These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7694850)

  • 1. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway.
    Holsen DS; Harthug S; Myrmel H
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):673-6. PubMed ID: 7694850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
    Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
    East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities.
    Hellard ME; Hocking JS; Crofts N
    Epidemiol Infect; 2004 Jun; 132(3):409-15. PubMed ID: 15188710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
    Poulin C; Courtemanche Y; Serhir B; Alary M
    Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.
    Hodžić H; Bajramović A; Obradović Z; Mahmić-Kaknjo M
    Med Glas (Zenica); 2017 Feb; 14(1):73-78. PubMed ID: 28165441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon.
    Mahfoud Z; Kassak K; Kreidieh K; Shamra S; Ramia S
    J Infect Dev Ctries; 2010 Mar; 4(3):144-9. PubMed ID: 20351454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
    Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
    Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous drug abuse--the major route of hepatitis C virus transmission among alcohol-dependent individuals?
    Verbaan H; Andersson K; Eriksson S
    Scand J Gastroenterol; 1993 Aug; 28(8):714-8. PubMed ID: 7692588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
    SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
    Int J Prison Health; 2023 Nov; 19(4):536-544. PubMed ID: 36757302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tattooing as a risk of hepatitis C virus infection.
    Ko YC; Ho MS; Chiang TA; Chang SJ; Chang PY
    J Med Virol; 1992 Dec; 38(4):288-91. PubMed ID: 1282147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users.
    Anastassopoulou CG; Paraskevis D; Sypsa V; Psichogiou M; Katsoulidou A; Tassopoulos N; Skoutelis A; Malliori M; Hatzakis A
    J Med Virol; 1998 Nov; 56(3):246-52. PubMed ID: 9783693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
    Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
    Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus in intravenous drug users.
    Bell J; Batey RG; Farrell GC; Crewe EB; Cunningham AL; Byth K
    Med J Aust; 1990 Sep; 153(5):274-6. PubMed ID: 2118227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland.
    Hruby Z; Sliwiński J; Molin I; Zalewska M; Knysz B; Czyz W; Steciwko A; Bogucki J; Gładysz A
    Nephrol Dial Transplant; 1993; 8(8):740-3. PubMed ID: 7692355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for viral hepatitis among male non-drug-abuse prisoners.
    Liao KF; Lai SW; Chang WL; Hsu NY
    Scand J Gastroenterol; 2006 Aug; 41(8):969-73. PubMed ID: 16803696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.